Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Would you offer RT to a patient who had a RP showing pT3b pN1 Gleason 9 prostate cancer with elevated post-op PSA?
Would it matter if their PET axumin was negative?
Answer from: Radiation Oncologist at Academic Institution
If Axumin PET is negative for metastatic sites (prostatic Bed or Pelvic Nodes are excluded) Or even totally negative, I would treat.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
I would favor pet scan if meets threshold based on psa and plan treatment accordingly
Sign in or Register to read more
6190
6181
Related Questions
Which genomic test do you choose for a patient with favorable intermediate prostate cancer trying to decide between active surveillance and treatment?
Given the different rates of testosterone recovery, do you alter the duration of ADT when using Leuprorelin (GnRH Agonist) vs relugolix (GnRH antagonist) in patients with intermediate or high-risk prostate cancer who received definitive radiation?
When do you start ADT for a patient with a new diagnosis of node positive prostate cancer receiving radiation?
What data support the use of continuing GnRH therapy "backbone" in metastatic castration resistant prostate cancer (mCRPC) receiving additional therapies?
As PARTIQoL was a negative study, what is the current role for proton therapy in the management of prostate cancer patients?
How do you counsel/advise patients when asked to compare ultrahypofractionated radiotherapy with the TULSA procedure?
In asymptomatic patients with castrate resistant prostate cancer who have failed chemotherapy and have progressive vertebral body metastases, when do you prescribe lutetium-177 vs prophylactic spinal radiation?
What duration androgen deprivation do you recommend with salvage pelvic radiotherapy for pelvic node relapse after prostatectomy?
How would you optimally boost patients with high or very high risk prostate cancer receiving definitive radiotherapy in 2025?
How long would you delay prostate radiation following use of a paclitaxel-eluting balloon dilator (optilume) for management of a recurrent urethral stricture after TURP?